MRSA Treatment and Molecular Geometry/ Bonding Pharmaceutical Chemistry TIP By: James Gorman Dr. Philip Deshong University of Maryland.

Slides:



Advertisements
Similar presentations
Hospital-acquired and community-acquired MRSA in hospitals
Advertisements

NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
EX. 20 Antibiotic Disk Sensitivity
Jeopardy Cell Wall Plasma Membrane DNA Anti- metabolite Protein Translation Q $100 Q $200 Q $300 Q $400 Q $500 Q $100 Q $200 Q $300 Q $400 Q $500 Final.
Introduction to molecular biology. Subjects overview Investigate how cells organize their DNA within the cell nucleus, and replicate it during cell division.
Control of Microbial Growth Tim Ho University of Alberta, Canada * The materials are mostly based on Dr. Brian Lanoil’s Microb Part.
And Penicillins.  Though antimicrobials have been around forever, we have only known about them since the late 1920’s.  A fungal contaminant on a bacterial.
Synthesis of Vancomycin from the Aglycon Christopher Thompson, Min Ge, Daniel Kahne J. Am. Chem. Soc. 1999, 121, Presented by James Melnyk.
Antimicrobial Susceptibility Testing – Part II
Bacterial Physiology (Micr430) Lecture 10 Macromolecular Synthesis: Cell Wall (Text Chapter: 11)
Conjugative DNA transfer, antibiotic resistance and MDR bacteria With thanks to Steve Matson Who first created this lecture.
1 Antimicrobial Therapy Chemotherapy: any treatment of patient with chemicals to treat a condition. –Now word associated with cancer treatment –Our focus.
DENS 521 Clinical Dental Therapeutics
Antibiotic Resistance Antibiotics were introduced as therapeutic agents against bacterial disease starting in Major classes of antibiotics attained.
Pharmacology-1 PHL nd Term 9 th Lecture By Abdelkader Ashour, Ph.D. Phone:
1 Antimicrobial Therapy Chemotherapy: any treatment of patient with chemicals to treat a condition. –Now word associated with cancer treatment –Our focus.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
Epidemiology and Control of Methicillin-Resistant Staphylococcus aureus in hospitals Maria Kapi,MD Registrar of Medical Microbiology Laiko General Hospital.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
Cell Wall By Megarathan.J. ❖ Gives shape to a cell ❖ provides rigidity to a cell ❖ nm thick ❖ 20-30% of the dry weight of the cell ❖ Permeable to.
Antibiotics; Inhibitors of Cell Wall Synthesis LECTURE 10: Microbiology and Virology; 3 Credit hours Atta-ur-Rahman School of Applied Biosciences (ASAB)
Chapter 1: Introduction to the resistance problem.
Antibiotics Bio February 2010 Ethan Richman Ben Kwak Ampicillin, Tetracyclin, and Chloramphenicol.
Environmental Factors that Influence Microbes Including Antimicrobial Agents.
Mechanisms of antimicrobial action directed against the bacterial cell wall and corresponding resistance mechanisms M-4 Advanced Therapeutics Course.
CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING ANTIBIOTIC RESISTANCE Dr. Jolanta Miciulevičienė Vilnius City Clinical Hospital National Public Health.
Are we entering a post-antibiotic era?
Prokaryotic Life Characteristics Reproduction Evolution.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 83 Basic Principles of Antimicrobial Therapy.
Antibiotic Resistance
Frequency of Antibiotic Resistance among Bacteria Isolated From a High School Setting Katie Amato Columbia High School.
Molecular Basis of Vancomycin Resistance-Basic Science Paper Yashar Kalani Biochemistry 230.
Is The Prevalence of Staphylococcus aureus Increasing Among York College Students? By: Angel Newson Department of Biological Sciences, York College of.
Chapter 1 Morphology and properties of bacteria Belong to the prokaryote kingdom,the absence of a nuclear membrane and mitotic apparatus and the absence.
Introduction to Antimicrobials. General Terms Chemotherapy Antibiotic – substance produced by a microbe that may harm another microbes Antimicrobial –
Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus Chloe Jones Loyola Marymount University BIOL368:
Yoga Mats Support the Growth of Staphylococcus aureus Tiffany King, Department of Biological Science, York College of Pennsylvania Introduction  Staphylococcus.
Microbes and Medicine Streptomyces griseus Penicillium in Antibiotic Production.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Antibiotic Resistance in Microbes A few microbes to be concerned about How some antibiotics and Antimicrobials work Resistance mechanisms Some factors.
Pharmacology Unit 2: Applied Surgical Pharmacology Elsevier items and derived items © 2006 by Saunders, an imprint of Elsevier Inc.
Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus Bobby Arnold Alex Cardenas Zeb Russo Loyola.
Case 1  Tunyapon Sasithorn Pharmacology Clinical case.
Conjugative DNA transfer, antibiotic resistance and MDR bacteria With thanks to Steve Matson Who first created this lecture.
Antibiotic Resistance-MRSA Fungi –chitin(glucosamine)
Ana Bernal Brittany Soto BioQuest Consortium at UTK 17 August 2012
1 Drugs that Inhibit Cell wall synthesis Beta-lactams –Penicillin family –Cephalosporin family –Carbapenems and Monobactams –Β-lactamase inhibitors Vancomycin.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Copyright (c) 2004 Elsevier Inc. All rights reserved. Basic Principles of Antimicrobial Therapy Chapter 79.
DENS 521 Clinical Dental Therapeutics 2 nd Lecture By Abdelkader Ashour, Ph.D. Phone:
1 The Cell Envelope External covering outside the cytoplasm Composed of two basic layers: –Cell wall and cell membrane Maintains cell integrity 8/18/12Mickey.
Differentiation of Bacteria by Cell Wall Composition.
Ch. 10 Part 3 Antibiotics vs. Vaccines. Antibiotics Must call for extra help…Medicine/drugs called ANTIBIOTICS Drugs used to treat or kill bacterial or.
Drug design and discovery New and old drugs. Secondary stage rash in syphylis on the palms of the hands. Bacteria Treponema pallidum Old drugs: treated.
PRINCIPLES OF ANTIBIOTIC THERAPY
Antibiotics; Inhibitors of Cell Wall Synthesis
Patrick: An Introduction to Medicinal Chemistry 5e
Bacterial Targets for Antimicrobial Therapy
Drugs /Agents Inhibitors of cell wall synthesis
Cephalosporin and Other Cell Wall Synthesis Inhibitors
Antibiotics.
Drugs that Inhibit Cell wall synthesis
Chapter 20 Antibacterial Agents
Antimicrobial Medications
Antibiotic Resistance
Advisor: Dr. Stephanie Booth
Drug Resistance Bacteria are considered resistant to an antibiotic if the maximal level of that antibiotic that can be tolerated by the host does not halt.
Timeline of selected antibiotic development and reported resistance
Volume 7, Issue 5, Pages R109-R119 (May 2000)
Presentation transcript:

MRSA Treatment and Molecular Geometry/ Bonding Pharmaceutical Chemistry TIP By: James Gorman Dr. Philip Deshong University of Maryland

Warm-up Activity Comment on the following: “Though there are several types of staph infections, the one causing concern among health professions is methicillin- resistant staphylococcus aureus, or MRSA, a bacterium that is resistant to certain types of antibiotics. Several cases of MRSA have been confirmed in Massachusetts this fall, including schools in Winchester and Wrentham.” (Lefferts, Jennifer F. 2007)

Overview  Prevalence of Staphylococcus aureus  Cell Wall - Importance and Structure  Cell Wall - Construction  Cell Wall – Antibiotic target  Overview of methicillin resistance  Vancomycin  Vancomycin resistance

S. aureus Prevalence % Nasal Colonization of Population  Permanently - 20%  Transient - 60%  Never- 20% (Peacock et al. 2001) EM image of S. aureus (Paustian 2006)

Cell Wall – Importance & Structure  Mechanically supports the more flimsy cell membrane.  nm thick  Composed of  Peptidoglycans  Teichoic acids  Surface proteins (Todar 2005)

Cell Wall – Construction 1.Construction of peptidoglycan monomer. 2. Addition of pentaglycine cross-linker 3. Transglycosylation to outside of membrane 4. Transpeptidation to form cell wall (Fluit and Schmitz 2003)

Peptidoglycan Activity  See hand out for hands-on activity Dmitriev 2004

Peptidoglycan Cross-linking  Glycan chain adopts helical structure allowing the pentapeptide chains to adopt a zigzag conformation facilitating the construction of a scaffold-like cell wall structure (Dmitriev 2004)

Cell Wall – Antibiotic Target   -lactams compete with the D -Ala- D -Ala portion of peptidoglycan inhibiting cross-linking.  Bacteria fight back by degrading  -lactam ring

Vancomycin – “Drug of Last Resort”  Vancomycin is a peptide-based antibiotic produced by Amycolatopsis orientalis, a soil bacteria.  Unlike  -lactams, it cannot be administered orally but by IV.  Toxic compound which requires blood levels to be constantly monitored in the hospital.

Vancomycin Hands-on Activity  See hand out L-vancosamine D-glucose

Vancomycin - Mechanism  folds into a bowl shaped molecule  C-terminal L -Lys- D -Ala- D -Ala fits into this groove  5 hydrogen bonds are formed (Knox et al. 1990)

Vancomycin - Resistance  Naturally found in vancomycin producing bacteria as a set of 3 genes (VanA, H, and X)  Involves replacement of terminal D -Ala with D -lactate (Lessard and Walsh’s 1999)

VanX Mechanism  Zn(II)-containing metalloenzyme which removes the terminal D-Ala. (Mathews 2006)

Effect of D -Lactate  1000 fold reduction in affinity!!!  Structurally  Amine linking the D -Ala’s changes to ketone  Bonding  Eliminates a hydrogen bond  Introduces lone pair repulsion between carbonyl groups. Hands-on- Produce this molecular change in peptidoglycan and point out the changes. (Bugg et al. 1991)

Homework Assignment  Internet Research  Name one other class antibiotics  What is this class’ common target?  Sketch the molecular structure of an antibiotic from this class  Provide a brief description of the molecular geometry of this compound and how it interacts with its target molecule.

Works Cited  Bugg, Timothy; G. Wright, S. Dutka-Malen, M. Arthur, P. Courvailin, and C. Walsh. “Molecular Basis for Vancomycin Resistance in Enterococcus faecium BM4147: Biosynthesis of Depsipeptide Peptidoglycan Precursor by Vancomycin Resistance Proteins VanH and VanA.” Biochemistry 30 (1991):  Dmitriev, Boris A., Filip V. Toukach, O. Holst, E. T. Rietschel, and S. Ehlers. “Tertiary Structure of Staphylococcus aureus Cell Wall Murein.” Journal of Bacteriology 2004:7141–7148.  Lefferts, Jennifer F. “Schools trying to stay ahead of staph infections.” The Boston Globe Nov. 11, 2007: A.  Lessard, Ivan; Walsh, Christopher. “VanX, a bacterial D-alanyl-D-alanine dipeptidase: Resistance, immunity, or survival function?” Proc. Natl. Aced. Sci :  Knox, James R. and R. F. Pratt Antimicrobial Agents and Chemotherapy. 34(7) 1990:  Paustian, T, comp. Microbiology and Bacteriology: the World of Microbes Dec  Peacock, S. J., de Silva, I. & Lowy, F. D. “What determines nasal carriage of Staphylococcus aureus?” Trends Microbiol. 9 (2001):605–610.